The cost-effectivness of OM-86 in managing respiratory tract infections in China
To demonstrate the health economic impact of OM-85, a bacterial lysates based immunostimulant, for approved indications in China
Journal of Medical Economics
Xuan, Jianwei; Wang, Lijie; Yin, Hongjun; Xuan, Dennis; Zhou, Yan; and Hu, Shanlian, "The cost-effectivness of OM-86 in managing respiratory tract infections in China" (2015). PCOM Scholarly Papers. 998.
This document is currently not available here.